Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Mark the date it was first removed from refrigeration to track this 21-day window accurately
Just as importantly, the addition of extra ingredients creates a formulation that differs from the branded products, which compounders may use as a legal justification to avoid producing an outright copy of a brand-name drug.Recall Initiation Date: July 18, 2025Link: FDA Enforcement Report Semaglutide Company: Boothwyn Pharmacy, LLC (licensed compounding pharmacy)Location: Kennett Square, PennsylvaniaScope: Semaglutide, 2.5 mg/mL injection: .8 mL (186 vials), 2 mL (642 vials), 4 mL (648 vials)Drug Description: Treats type 2 diabetes and obesityRecall Reason: Subpotent drugs (which means they less than the specified amount of active ingredient)Recall Initiation Date: July 9, 2025Link: FDA Enforcement Report Semaglutide, Semaglutide/Cyanocobalamin, Tirzepatide, Tirzepatide/Cyanocobalamin Company: Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)Location: Englewood, ColoradoScope: Semaglutide: 5 mg/mL (164 pre-filled syringes)
With weekly injectable Wegovy , about 44% of patients at the highest dose reported nausea, and around 30% reported diarrhea
Incorrect administration can render the medication ineffective due to poor absorption
References Falutz J, et al
US$ 21.74
US$ 20.91
US$ 20.25
US$ 20.13
US$ 29.46
US$ 29.75
US$ 20.85
US$ 22.21
US$ 28.98
US$ 23.35
US$ 20.43
US$ 28.91
